Literature DB >> 10526053

Bile duct cancer developed after cyst excision for choledochal cyst.

Y Watanabe1, A Toki, T Todani.   

Abstract

Oncogenesis after cyst excision for choledochal cyst and suitable surgical procedures for this operation are discussed. The clinical data of 23 patients with cancer of the biliary tree after excision of choledochal cyst reported in the English-language and Japanese literature were reviewed, and data for 1353 Japanese patients with choledochal cyst and/or pancreaticobiliary malunion were analyzed. In the 23 patients reported in the literature, age at cyst excision ranged from 1 to 55 years (average, 23.0 +/- 13.7 years), and cancers were detected at age 18-60 years (average, 32.1 +/- 12.2 years), with intervals between cyst excision and cancer detection of 1-19 years (average, 9.0 +/- 5.5 years). Sites of cancer development were: intrahepatic, six; anastomotic, eight; hepatic side residual cyst, three; and the intrapancreatic duct, six. In the Japanese patients with choledochal cyst and/or pancreaticobiliary malunion, the incidence of cancer associated with primary choledochal cyst and/or pancreaticobiliary malunion was 16.2% (219/1353). The incidence of cancer development after cyst excision in this population, of whom 1291/1353 underwent surgery, was assumed to be 0. 7%. Nearly half of the 23 patients in the literature had undergone inadequate cyst excision. Oncogenesis of cancers after cyst excision is possibly different from that of choledochal cysts.

Entities:  

Mesh:

Year:  1999        PMID: 10526053     DOI: 10.1007/s005340050108

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  63 in total

1.  Choledochal Cystic Diseases.

Authors:  Stephen D. Bruns; Thomas A. Broughan
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

2.  Management of type I choledochal cyst in adult: totally laparoscopic resection and Roux-en-Y hepaticoenterostomy.

Authors:  Yu Tian; Shuo-Dong Wu; An-Dong Zhu; De-Xing Chen
Journal:  J Gastrointest Surg       Date:  2010-06-22       Impact factor: 3.452

Review 3.  Japanese clinical practice guidelines for pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Hisami Ando; Masafumi Suyama; Mitsuo Shimada; Yuji Morine; Hiroshi Shimada
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

4.  Role of magnetic resonance cholangiopancreatography in diagnosing choledochal cysts: Case series and review.

Authors:  Vikas Y Sacher; James S Davis; Danny Sleeman; Javier Casillas
Journal:  World J Radiol       Date:  2013-08-28

Review 5.  Choledochal cysts. Part 3 of 3: management.

Authors:  Janakie Singham; Eric M Yoshida; Charles H Scudamore
Journal:  Can J Surg       Date:  2010-02       Impact factor: 2.089

Review 6.  Choledochal cysts: part 1 of 3: classification and pathogenesis.

Authors:  Janakie Singham; Eric M Yoshida; Charles H Scudamore
Journal:  Can J Surg       Date:  2009-10       Impact factor: 2.089

Review 7.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

8.  Higher expression of phosphorylated myosin regulatory light chain in the common bile duct in pancreaticobiliary maljunction accompanied by bile duct dilatation in children: a post-mortem observational study.

Authors:  Wan-liang Guo; Qi Zhang; Jian Wang; Mei-fang Jin
Journal:  Pediatr Surg Int       Date:  2012-12-09       Impact factor: 1.827

Review 9.  Preemptive surgery for premalignant foregut lesions.

Authors:  Rohit R Sharma; Mark J London; Laura L Magenta; Mitchell C Posner; Kevin K Roggin
Journal:  J Gastrointest Surg       Date:  2009-06-10       Impact factor: 3.452

10.  Choledochal cysts: analysis of disease pattern and optimal treatment in adult and paediatric patients.

Authors:  Janakie Singham; David Schaeffer; Eric Yoshida; Charles Scudamore
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.